116 related articles for article (PubMed ID: 2417705)
1. Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia.
Zimm S; Reaman G; Murphy RF; Poplack DG
Cancer Res; 1986 Mar; 46(3):1495-8. PubMed ID: 2417705
[TBL] [Abstract][Full Text] [Related]
2. Increased PRPP synthetase activity in cultured rat hepatoma cells containing mutations in the hypoxanthine-guanine phosphoribosyltransferase gene.
Graf LH; McRoberts JA; Harrison TM; Martin DW
J Cell Physiol; 1976 Jul; 88(3):331-42. PubMed ID: 178676
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell hypoxanthine phosphoribosyltransferase activity measured using 6-mercaptopurine as a substrate: a population study in children with acute lymphoblastic leukaemia.
Lennard L; Hale JP; Lilleyman JS
Br J Clin Pharmacol; 1993 Oct; 36(4):277-84. PubMed ID: 12959304
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of 6-mercaptopurine in human leukemic cells.
Higuchi T; Nakamura T; Wakisaka G
Cancer Res; 1976 Oct; 36(10):3779-83. PubMed ID: 821607
[TBL] [Abstract][Full Text] [Related]
5. Activities of amidophosphoribosyltransferase (EC2.4.2.14) and the purine phosphoribosyltransferases (EC2.4.2.7 and 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development--their possible relationship to the neurological dysfunction in the Lesch-Nyhan syndrome.
Allsop J; Watts RW
J Neurol Sci; 1980 May; 46(2):221-32. PubMed ID: 6155447
[TBL] [Abstract][Full Text] [Related]
6. Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines.
Zimm S; Johnson GE; Chabner BA; Poplack DG
Cancer Res; 1985 Sep; 45(9):4156-61. PubMed ID: 2411397
[TBL] [Abstract][Full Text] [Related]
7. On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitro.
Liliemark J; Pettersson B; Peterson C
Leuk Res; 1992; 16(3):275-80. PubMed ID: 1373210
[TBL] [Abstract][Full Text] [Related]
8. Phosphoribosylpyrophosphate synthesis in cultured human cells.
Benke PJ; Dittmar D
Science; 1977 Dec; 198(4322):1171-3. PubMed ID: 201027
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study.
Adamson PC; Balis FM; Arndt CA; Holcenberg JS; Narang PK; Murphy RF; Gillespie AJ; Poplack DG
Cancer Res; 1991 Nov; 51(22):6079-83. PubMed ID: 1933871
[TBL] [Abstract][Full Text] [Related]
10. Correlation of enhanced 6-mercaptopurine cytotoxicity with increased phosphoribosylpyrophosphate levels in Chinese hamster ovary cells treated with 3-aminobenzamide.
Moses K; Willmore E; Harris AL; Durkacz BW
Cancer Res; 1990 Apr; 50(7):1992-6. PubMed ID: 1690594
[TBL] [Abstract][Full Text] [Related]
11. Kinetic mechanism of human hypoxanthine-guanine phosphoribosyltransferase: rapid phosphoribosyl transfer chemistry.
Xu Y; Eads J; Sacchettini JC; Grubmeyer C
Biochemistry; 1997 Mar; 36(12):3700-12. PubMed ID: 9132023
[TBL] [Abstract][Full Text] [Related]
12. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV
Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360
[TBL] [Abstract][Full Text] [Related]
13. Application of HPLC to study the kinetics of a branched bi-enzyme system consisting of hypoxanthine-guanine phosphoribosyltransferase and xanthine oxidase--an important biochemical system to evaluate the efficiency of the anticancer drug 6-mercaptopurine in ALL cell line.
Kalra S; Paul MK; Balaram H; Mukhopadhyay AK
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):7-14. PubMed ID: 17081813
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity.
Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR
Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145
[TBL] [Abstract][Full Text] [Related]
15. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
[TBL] [Abstract][Full Text] [Related]
16. Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts.
Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RR; Schretlen ED; van Laarhoven JP; De Bruyn CH
Biochem Pharmacol; 1986 Oct; 35(20):3549-55. PubMed ID: 2429667
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
[TBL] [Abstract][Full Text] [Related]
18. Induction of millimolar amounts of 5-phosphoribosyl-1-pyrophosphate in human erythrocytes by incubation in inosine-pyruvate-phosphate medium. A 31P-NMR study.
Petersen A; Quistorff B
Biomed Biochim Acta; 1990; 49(2-3):S111-6. PubMed ID: 1696811
[TBL] [Abstract][Full Text] [Related]
19. Interrelationship of number of glucose carriers and intracellular phosphoribosyl diphosphate level of Ehrlich ascites tumor cells in vitro.
Choy YM; Lam WP; Fung KP
Cancer Biochem Biophys; 1988 Nov; 10(2):141-7. PubMed ID: 2472871
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of 6-mercaptopurine in human leukemic cells and phosphoribosylpyrophosphate.
Higuchi T
Nihon Ketsueki Gakkai Zasshi; 1975 Jun; 38(3):248-58. PubMed ID: 1243219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
